Intestinal Soft Tissue Neoplasm — knowledge graph · CancerIndex

Knowledge graph · Cancer

Intestinal Soft Tissue Neoplasm

subtype

Identifier: CI-CAN-00001026
Entity page: /cancer/intestinal-soft-tissue-neoplasm ↗
Edges: 10

Neighbours: 4 drugs6 trials
Drawn: 10 of 10 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Intestinal Soft Tissue Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Cetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Intestinal Soft Tissue Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Intestinal Soft Tissue Neoplasm studied in …STUDIED_INderived6 of 6
→ studied in	NCT04148378withdrawn A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer · condition mapped ONTOLOGY_EXACT · 6 trials mapped (1 active)	—	—	Colorectal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01793168recruiting Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford · condition mapped ALIAS · 6 trials mapped (1 active)	—	—	Small Intestinal Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ALIAS · 6 trials mapped (1 active)	—	—	Small Intestinal Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · condition mapped ALIAS · 6 trials mapped (1 active)	—	—	Small Intestinal Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00031681Phase 1 · completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) · condition mapped ALIAS · 6 trials mapped (1 active)	—	—	Small Intestinal Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00087191NA · terminated EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer · condition mapped ALIAS · 6 trials mapped (1 active)	—	—	Small Intestinal Leiomyosarcoma	1	Observed	clinicaltrials	graph →